NephroGenex, Inc. Proceeds from Issuance Initial Public Offering
NephroGenex, Inc. reported Proceeds from Issuance Initial Public Offering of $37.20 million for the 0-month period ending 2014-02-14, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2014-05-14
- 2014-02-14: Proceeds from Issuance Initial Public Offering 0 month $37.20M.
| Period end | Proceeds from Issuance Initial Public Offering 0 month |
|---|---|
| 2014-02-14 | $37.20M 10-Q · filed 2014-05-14 |